Resources
Presentations
CERTs Presentations 2003
Spreading the Word About CERTs (10k pdf)
December 4-7, 2003
2nd Elements of Success Conference
The Art of Assessing Adherence to ART
Robert Gross, MD, MSCE
Dallas, Texas
December 2, 2003
Targeted Research Enhancement Program (TREP) - Lecture Series
CERTs: Reducing Medication Errors
Raymond L. Woosley, MD, PhD
Tucson, Arizona
December 2, 2003
Eisenberg Memorial Lectureship at the Medical University of South
Carolina
A System Goal: Benefit the Patient, Manage the Risk
Robert M. Califf, MD
Charleston, South Carolina
November 24, 2003
University of Maryland, School of Pharmacy, Center for Drugs and Public Policy
Opportunities in CERTs for Graduate Students in Pharmaceutical
Policy and Administration
William H. Campbell, PhD
College Park, MD
November 24, 2003
University of Arizona National Center of Excellence in Women's
Health Research Seminar Series
Drug Induced QT Prolongation: Not Just a Guy Thing
Raymond L. Woosley, MD, PhD
Tucson, Arizona
November 19, 2003
Eisenberg Memorial Lectureship at the Baylor College of Medicine
Evaluating Programs and Policies to Improve Therapeutics
Wayne Ray, PhD
Houston, Texas
November 19, 2003
Eisenberg Memorial Lectureship at the Regenstrief Institute
Using Drugs Well: What Do We Need To Know And How Can We Know It?
Richard Platt, MD, MS
Indianapolis, Indiana
November 14, 2003
Eisenberg Memorial Lectureship at the University of Colorado Health
Sciences Center
Drug-Drug Interactions, Pharmacokinetics and Pharmacodynamic Differences
Between Men and Women, Herbal Products
Daniel C. Malone, PhD; Marietta Anthony, PhD; Lane P. Johnson, MD, MPH
Denver, Colorado
November 8-12, 2003
American Medical Informatics Association Annual Fall Symposium
Developing a Patient Intervention to Reduce Antibiotic Overuse
John H. Holmes, PhD
Washington, DC
November 7, 2003
Rheumatology Grand Rounds - Johns Hopkins University
Glucocorticoid Induced Osteoporosis - How Can We Improve Quality of
Care?
Kenneth G. Saag, MD, MSc
Baltimore, Maryland
November 5, 2003
Eisenberg Memorial Lectureship at Creighton University
The Interface of Pharmaceutical Care, Therapeutics and Patient Safety
William Campbell, PhD; Diana Cousins, BS, RPh; Rowell Daniels, MS, PharmD
Omaha, Nebraska
November 3, 2003
International Society for Quality in Health Care’s 20th
International Conference
Patient Safety and Centers for Education and Research on Therapeutics
(panel)
Lynn A. Bosco, MD, MPH; Jeroan Allison, MD, MS; Norman Weissman, PhD
Dallas, Texas
October 29-30, 2003
Texas Children’s Cancer Center Research Seminar Series
Informatics and the TDM Renaissance: How to Integrate PK Intelligence
with Routine Clinical Data
Alexander A. Vinks, PharmD, PhD
Houston, Texas
October 17, 2003
Institute of Medicine of Chicago, Chicago Patient Safety Forum,
2003 Showcase of Patient Safety Improvements
Learning from Errors in Ambulatory Pediatrics (LEAP) (Poster)
Julie J. Mohr, MSPH, PhD; Carole Lannon, MD, MPH; Eric Slora, PhD; Mort
Wasserman, MD; Kathy Thoma, MS; David Kleckner; Lynne Uhring, MD; Donna
Woods, PhD
Chicago, Illinois
October 16, 2003
Eisenberg Memorial Lectureship at the University of California
at San Francisco
What Are Our Drugs Truly Doing to our Patients? Lessons from Pharmacoepidemiology
Brian L. Strom, MD, MPH
San Francisco, California
October 10-11, 2003
Infectious Diseases Society of America
Medication Refill Logistics and Adherence to Antiretroviral Therapy
(Poster)
Robert Grossberg, MD; Robert Gross, MD, MSCE
San Diego, California
October 8, 2003
University of Arizona, Anesthesia Grand Rounds
Drug-Induced Arrhythmias: Déjà Vu All Over Again
Raymond L. Woosley, MD, PhD
Tucson, Arizona
October 3, 2003
Program on Health Outcome Seminar Series
Overcoming Barriers to TDM: Information and the TDM Renaissance. How
to Integrate PK Intelligence with Routine Clinical Data.
Alexander Vinks, PharmD, PhD
Chapel Hill, North Carolina
October 3, 2003
Program on Health Outcome Seminar Series
Barriers to Therapeutic Drug Monitoring (TDM)
Philip Walson, MD
Chapel Hill, North Carolina
October 2, 2003
Vanderbilt University Medical Center Grand Rounds
Drug-Induced Arrhythmias: Déjà Vu All Over Again
Raymond L. Woosley, MD, PhD
Nashville, Tennessee
September 18-19, 2003
National Ambulatory Primary Care Research and Education Conference
on Patient Safety
LEAP – Learning from Errors in Ambulatory Pediatrics
Julie J. Mohr, MSPH, PhD; Carole Lannon, MD, MPH; Eric Slora, PhD; Mort
Wasserman, MD; Kathy Thomas, MS; David Kleckner; Lynne Uhring, MD; Donna
Woods, PhD
Chicago, Illinois
September 15, 2003
National Institute of Allergy and Infectious Diseases, Conference
on Clinical Studies in Pediatric Organ Transplantation: Defining Priorities
and Feasibility
Alternatives to Randomized Clinical Trials
Warren Bilker, PhD
Bethesda, Maryland
September 15, 2003
43rd Interscience Conference on Antimicrobial Agents and Chemotherapy
(ICAAC)
Meet-the-Expert: How Useful is Therapeutic Drug Monitoring?
John van den Anker, MD, PhD; Alexander A. Vinks, PharmD, PhD, FCP
Chicago, Illinois
September 12, 2003
8th International Congress of Therapeutic Drug Monitoring and
Clinical Toxicology
Cost-Effectiveness of Goal-Oriented Model-Based Therapeutic Drug Monitoring
Alexander A. Vinks, PharmD, PhD, FCP
Basel, Switzerland
August 23, 2003
19th International Conference on Pharmacoepidemiology and 1st
International Conference on Therapeutic Risk Management
Risk Management Improvement Through Research and Education: A Report
From an Unprecedented Set of Think Tanks
Hugh H. Tilson, MD, DrPH; Brian L. Strom, MD, MPH; William H. Campbell,
PhD; Judith M. Kramer, MD, MS; Lynn A. Bosco, MD, MPH
Philadelphia, Pennsylvania
August 22-24, 2003
19th International Conference on Pharmacoepidemiology and 1st
International Conference on Therapeutic Risk Management
Smallpox Vaccination: From Policy to Implementation (Symposium)
Worth W. Everett, MD; Brian L. Strom, MD, MPH
Philadelphia, Pennsylvania
August 22-24, 2003
19th International Conference on Pharmacoepidemiology and 1st
International Conference on Therapeutic Risk Management
Smallpox Vaccination: A National Survey of Emergency Healthcare Providers
Worth W. Everett, MD
Philadelphia, Pennsylvania
August 22-24, 2003
19th International Conference on Pharmacoepidemiology and 1st
International Conference on Therapeutic Risk Management
Failure to Validate Pneumococcal Pneumonia Diagnoses in the General
Practice Research Database
Joshua P. Metlay, MD, PhD; Judith Kinman, MA
Philadelphia, Pennsylvania
August 22-24, 2003
19th International Conference on Pharmacoepidemiology and 1st
International Conference on Therapeutic Risk Management
Multidisciplinary Perspectives on Managing the Risks of Therapeutic
Products
Judith M. Kramer, MD, MS
Philadelphia, Pennsylvania
August 22-24, 2003
19th International Conference on Pharmacoepidemiology and 1st
International Conference on Therapeutic Risk Management
The Epidemiology of Communication Errors During Antimicrobial Management
Telephone Interactions (Poster)
Darren Linkin, MD
Philadelphia, Pennsylvania
August 22-24, 2003
19th International Conference on Pharmacoepidemiology and 1st
International Conference on Therapeutic Risk Management
A System Goal: Benefit the Patient, Manage the Risk
Robert M. Califf, MD
Philadelphia, Pennsylvania
August 22-24, 2003
19th International Conference on Pharmacoepidemiology and 1st
International Conference on Therapeutic Risk Management
Nonfatal Myocardial Infarction Risk Among Users of Aspirin and Nonselective
Non-Aspirin Nonsteroidal Anti-Inflammatory Medications.
Stephen E. Kimmel, MD, MS; Jesse A. Berlin, ScD; Muredach Reilly, MBBCh;
Jane Jaskowiak, RN, BSN; Lori A. Kishel, MS; Brian L. Strom, MD, MPH
Philadelphia, Pennsylvania
August 22-24, 2003
19th International Conference on Pharmacoepidemiology and 1st
International Conference on Therapeutic Risk Management
Antibiotic Use and the Risk for Flares of Inflammatory Bowel Disease
Faten N. Aberra, MD; Colleen M. Brensinger, MS; Warren B. Bilker, PhD;
Brian L. Strom, MD, MPH; Gary R. Lichtenstein, MD; James D. Lewis, MD,
MSCE
Philadelphia, Pennsylvania
August 22-24, 2003
19th International Conference on Pharmacoepidemiology and 1st
International Conference on Therapeutic Risk Management
Evaluating Preference Effects in Partially Unblended, Randomized Clinical
Drug Trials
Scott D. Halpern, MD, PhD, MBE, MSCE
Philadelphia, Pennsylvania
August 22-24, 2003
19th International Conference on Pharmacoepidemiology and 1st
International Conference on Therapeutic Risk Management
Gout Epidemiology and Pharmacoepidemiology: Results from the General
Practice Research Database (GPRD)
Ted R. Mikuls, MD, MSPH; John T. Farrar, MD; MSCE, Warren B. Bilker, PhD;
Shawn Fernandes; Kenneth G. Saag, MD, MSc
Philadelphia, Pennsylvania
August 22-24, 2003
19th International Conference on Pharmacoepidemiology and 1st
International Conference on Therapeutic Risk Management
The Treatment of Asymptomatic Hyperuricemia: Results from the Population-based
General Practice Research Database (GPRD)
Ted R. Mikuls, MD, MSPH; John T. Farrar, MD, MSCE; Warren B. Bilker, PhD;
Shawn Fernandes; Kenneth G. Saag, MD, MSc
Philadelphia, Pennsylvania
August 22-24, 2003
19th International Conference on Pharmacoepidemiology and 1st
International Conference on Therapeutic Risk Management
Accuracy of Days Supply vs. Pills Dispensed in Medicaid Data
Robert Gross, MD, MS; Warren Bilker, PhD; Sean Hennessy, PharmD, PhD;
John T. Farrar, MD, MSCE; Brian L. Strom, MD, MPH
Philadelphia, Pennsylvania
August 22-24, 2003
19th International Conference on Pharmacoepidemiology and 1st
International Conference on Therapeutic Risk Management
Lack of Specific Cross-Reactivity Between Sulfonamide Antibiotics
and Subsequent Sulfonamide Non-Antibiotics
Brian L. Strom, MD, MPH; Rita Schinnar, MPA; Andrea J. Apter, MD; David
J. Margolis, MD, PhD; Ebbing Lautenbach, MD, MPH, MSCE; Sean Hennessy,
PharmD, PhD; Warren Bilker, PhD; Dan Pettitt, DVM
Philadelphia, Pennsylvania
August 22-24, 2003
19th International Conference on Pharmacoepidemiology and 1st
International Conference on Therapeutic Risk Management
Issues in the Determination Of Disease Prevalence From Medical Record
Databases: Cumulative Incidence in Chronic Diseases Such As Gout
John T. Farrar, MD, MSCE; Ted R. Mikuls, MD, MSPH; Kenneth G. Saag, MD,
MSc; Warren Bilker, PhD; Shawn Fernandes; Brian L. Strom, MD, MPH
Philadelphia, Pennsylvania
August 22-24, 2003
19th International Conference on Pharmacoepidemiology and 1st
International Conference on Therapeutic Risk Management
Introduction to the FDA Drug Safety and Risk Management Advisory Committee
Brian L. Strom, MD, MPH
Philadelphia, Pennsylvania
August 8, 2003
UNC Program on Health Outcomes, Summer Outcomes Day
Learning from Errors in Ambulatory Pediatrics
Julie J. Mohr, MSPH, PhD
Chapel Hill, North Carolina
August 8, 2003
5th Annual Santa Fe Bone Symposia
Osteoporosis in the Rheumatic Diseases
Kenneth G. Saag, MD, MSc
Santa Fe, New Mexico
July 23, 2003
American Association for Clinical Chemistry (AACC)
Overcoming Barriers to TDM: Information and the TDM Renaissance
Barriers to TDM: How to Get Good Clinical Data from the Hospital IS
Philip D. Walson, MD; Alexander A. Vinks, PharmD, PhD
Philadelphia, Pennsylvania
July 15, 2003
Bristol Meyer Squibb Pharmacovigilance Grand
Rounds
Improving Outcomes in Rheumatoid Arthritis
Kenneth G. Saag, MD, MSc
Princeton, New Jersey
July 14, 2003
FDA Workshop on SARS Diagnostics
Incorporating Diagnostic Testing Into Clinical Practice
Joshua Metlay, MD, PhD
Rockville, Maryland
July 1, 2003
International Symposium on Osteoarthritis Joint Pain
Lessons From Fibromyalgia
Laurence A. Bradley, PhD
London, England
June 19-20, 2003
Visiting Professor - University of Texas Southwestern Medical
Center
Problems with Allowing Doctors and Patients to Fly without a Cockpit
and Automated Pilot: The Glass Cockpit Project
Robert M. Califf, MD
Dallas, Texas
June 16, 2003
Drug Information Association 39th Annual Meeting
Report from an Unprecedented Series of Think Tanks: The CERTs Risk
Management Series
Hugh Tilson, MD, DrPH
San Antonio, Texas
June 7, 2003
Society for Vascular Medicine and Biology
Principles of Clinical Trails Applied to Vascular Medicine
Robert M. Califf, MD
Chicago, Illinois
June 24, 2003
University of Cincinnati, Pediatric Grand Rounds
Why It Is Unethical Not To Do Pediatric Clinical Trials
Philip D. Walson, MD
Cincinnati, Ohio
June 5, 2003
Robert Wood Johnson School of Medicine Pediatric Grand Rounds
National Progress in Patient Safety: Illusion or Reality?
Diane D. Cousins, BS, RPh
New Brunswick, New Jersey
May 22, 2003
University of Alabama at Birmingham Medical Grand Rounds
Glucocorticoids in Chronic Diseases: Bones of Contention
Kenneth G. Saag, MD, MSc
Birmingham, Alabama
May 21, 2003
Women’s and Children’s Hospital Pediatrics Grand Rounds
Why It Is Unethical Not To Do Pediatric Clinical Trials
Philip D. Walson, MD
Charleston, West Virginia
May 20, 2003
ISPOR Meeting
International Society for Pharmacoeconomics and Outcomes Research
Use of Outcomes Research Date in Assuring Patient Safety and Quality
of Care
Robert M. Califf, MD
Arlington, Virginia
May 20, 2003
Institute of Medicine Meeting
IOM Committee on Assessing the Need for Clinical Trials of Testosterone
Replacement Therapy
Robert M. Califf, MD
Washington, DC
May 18-21, 2003
ISPOR 8th Annual International Meeting
A Randomized Controlled Trial of a Drug Use Review Intervention for
Antibiotics Medications for Otitis Media
Yoonsook Lee, MS; Dale B. Christensen, PhD; Anu Ayyar-Krishnan, MS
Arlington, Virginia
May 15-18, 2003
The 20th Annual Primary Care & Family Medicine Update
Nonsteroidal Anti-Inflammatory Drugs: What’s New?
Marie R. Griffin, MD, MPH
Nashville, Tennessee
May 14-17, 2003
American Academy of Pediatrics Super CME 2003
eQIPP Workshop – Advancing ADHD Care
Carole Lannon, MD, MPH
Chicago, Illinois
May 13-17, 2003
McClelland Visiting Professor
Heart Failure—Progress In Therapeutics
Therapy for Acute Coronary Syndromes
The Medical Mistakes You Hear About Are Only the Tip Of The Iceberg
Revascularization—Where Are We Headed?
Robert M. Califf, MD
San Francisco, California
May 8-9, 2003
Translating Research Into Practice
Financial Disincentives to Optimal Therapy
Robert M. Califf, MD
Winston-Salem, North Carolina
May 6-7, 2003
Visiting Professor – Johns Hopkins Hospital
An Academic Model of Clinical Research Applied to Heart Failure
Robert M. Califf, MD
Baltimore, Maryland
May 6, 2003
2003 Pediatric Academic Society Annual Meeting
Pre-Event Vaccination Against Smallpox: A Survey Of Pediatric Emergency
Healthcare Providers
Theo E. Zaoutis, MD
Seattle, Washington
April 16-18, 2003
Visiting Professor – Mayo Clinic
The Cycle of Medical Quality applied to Acute Coronary Syndromes
Clinical Trials in Heart Failure: What Have We Learned?
Robert M. Califf, MD
Rochester, Minnesota
April 10, 2003
Academy of Managed Care Pharmacy Annual Meeting
Identifying and Preventing Clinically Important Drug-Drug Interactions
Identifying and Preventing Clinically Important Drug-Drug Interactions:
Concordance Among Compendia & Selection Process
Daniel C. Malone, PhD; Jacob Abarca, PharmD, MS
Minneapolis, Minnesota
April 5-8, 2003
13th Annual Meeting of the Society for Healthcare Epidemiology
of America (SHEA)
Public Health Preparedness and Antimicrobial Utilization Among Emergency
Department Physicians During the 2001 Bioterrorism Anthrax Outbreak
Nkuchia M’ikanatha, MPH, DrPH
Arlington, Virginia
April 5-8, 2003
13th Annual Meeting of the Society for Healthcare Epidemiology
of America (SHEA)
Impact of the Web on Enhancing Infectious Disease Reporting and Bioterrorism
Preparedness: Current Capabilities and Future Promise
Nkuchia M’ikanatha, MPH, DrPH
Arlington, Virginia
April 5-8, 2003
13th Annual Meeting of the Society for Healthcare Epidemiology
of America (SHEA)
Fluoroquinolone Resistance in Enterobacteriaceae: Significant Differences
in Longitudinal Trends Across Organisms and Inpatient and Outpatient Settings
Ebbing Lautenbach, MD, MPH, MSCE
Arlington, Virginia
April 7, 2003
13th Annual Meeting of the Society for Healthcare Epidemiology
of America (SHEA)
The Epidemiology of Communication Errors During Telephone Antimicrobial
Management Interactions
Darren Linkin, MD
Arlington, Virginia
April 3, 2003
American Society for Clinical Pharmacology and Therapeutics (ASCPT)
Interpretation of Pediatric TDM Findings Workshop: THE – Therapeutic
Drug and Toxicology Monitoring is Affected by Age/Gender Difference
Alexander A. Vinks, PharmD, PhD, FCP
Washington, DC
April 3, 2003
American Society for Clinical Pharmacology and Therapeutics (ASCPT)
What Are Our Drugs Truly Doing to Our Patients? Lessons from Pharmacoepidemiology
Brian L. Strom, MD, MPH
Washington, DC
April 1, 2003
9th Annual HMO Research Network Conference
Collaborations in Therapeutics Education and Research
Richard Platt, MD, MS; Joe Selby, MD, MPH; Susan Andrade, ScD; David Magid,
MD, MPH
Denver, Colorado
April 1, 2003
9th Annual HMO Research Network Conference
Methods, Statistics and Results Track: Lessons Learned from HMORN
Collaborative Trials CRN, VSD, CERTs Work Groups
Sarah Greene, MPH; Jason Glanz; Arnold Chan, MD, ScD
Denver, Colorado
March 30, 2003
American College of Cardiology (ACC) 52nd Annual Scientific Session
Long Term Adherence to Evidence-Based Therapies for Coronary Artery
Disease and Heart Failure in the Outpatient Setting
Nancy Allen LaPointe, PharmD
Chicago, Illinois
March 20-21, 2003
AHRQ Partnership for Quality Meeting
Partnership to Improve Children's Healthcare Quality
Carole Lannon, MD, MPH
Rockville, Maryland
March 13, 2003
NIH Department of Health & Human Services General Clinical
Research Center (GCRD) Annual Meeting, K30 Clinical Research Awardees
Meeting
Infrastructure Support for Clinical Research Training
Brian L. Strom, MD, MPH
Baltimore, Maryland
March 12, 2003
Pfizer Advanced Clinical Research Program
Improving Cardiovascular Drug Therapy: The Duke Center for Education
and Research on Therapeutics
Judith M. Kramer, MD, MS
Durham, North Carolina
March 7-12, 2003
American Academy of Allergy Asthma & Immunology 60th Anniversary
Meeting
Incidence of Events Consistent With Hypersensitivity Reactions to
Penicillin in a Large Electronic Medical Record Database
Andrea Apter, MD, MA, MSc
Denver, Colorado
March 11, 2003
28th Annual Primary Care Update
20 Herbs to Remember
Lane Johnson, MD, MPH
Tucson, Arizona
March 8, 2003
International Congress on Glucocorticoid-Induced Osteoporosis
ACR and Other Recent Guidelines on GIOP Prevention and Treatment
Kenneth G. Saag, MD, MSc
Turin, Italy
March 6, 2003
Institute of Medicine Clinical Research Roundtable
The CERTs Model for Public-Private Partnership
Hugh Tilson, MD, DrPH
Washington, DC
March 6, 2003
CERTs Risk Series Strategic Symposium: “Benefit the Patient,
Manage the Risk,” 3rd Annual PATHs Meeting
Highlights of the Risk Series Think Tanks Panel
Robert M. Califf, MD
Arlington, Virginia
March 5, 2003
CERTs Risk Series Strategic Symposium: “Benefit the Patient,
Manage the Risk,” 2nd Annual Government Day Meeting
Benefit Assessment
Lynn A. Bosco, MD, MPH; Robert M. Califf, MD; William H. Campbell, PhD;
Judith M. Kramer, MD, MS; Brian L. Strom, MD, MPH
Bethesda, Maryland
March 3-5, 2003
National Initiative for Children’s Healthcare Quality 2nd
Annual Forum for Improving Children’s Health Care
Partnerships for Quality in Care for Children with ADHD
Carole Lannon, MD, MPH
Orlando, Florida
March 3-5, 2003
National Initiative for Children’s Healthcare Quality 2nd
Annual Forum for Improving Children’s Health Care
All Improvement is Local: Statewide Improvement Partnerships
Carole Lannon, MD, MPH
Orlando, Florida
March 3-5, 2003
National Initiative for Children’s Healthcare Quality 2nd
Annual Forum for Improving Children’s Health Care
Creating a Regional Pediatric Improvement Initiative
Carole Lannon, MD, MPH
Orlando, Florida
March 1, 2003
Hepatitis C New Drug & Clinical Trials Development: Promises
and Pitfalls
Designing Clinical Trials: The Investigator’s Perspective
Robert M. Califf, MD
Chicago, Illinois
February 26-27, 2003
NIAID and NHLBI Meeting
Cost Effectiveness of Medical Devices
Robert M. Califf, MD
Rockville, Maryland
February 23, 2003
36th Annual Southwestern Clinical Pharmacy Seminar
Clinically Important Drug-Drug Interactions: Which Ones Are They?
Daniel C. Malone, PhD, RPh
Tucson, Arizona
February 3, 2003
Public Health Grand Rounds, University of Arizona, Arizona State
University, Northern Arizona University
Clinically Important Drug-Drug Interactions: A Population-Based Assessment
Daniel C. Malone, PhD, RPh
Tucson, Arizona
February 1, 2003
North Carolina Pediatric Society Winter Open Forum
ADHD Collaboratives and NICHQ
Carole Lannon, MD, MPH
Greenville, North Carolina
January 31, 2003
University of Utah, K30 Lectureship
Drug Resistant Pneumococcal Disease: Challenges and Opportunities
Joshua P. Metlay, MD, PhD
Salt Lake City, Utah
January 30-31, 2003
Clinical Research Road Map Meeting
Establish a National Integrated Clinical Research System
Bethesda, Maryland
January 29, 2003
University of Arizona Center for Health Outcomes and PharmacoEconomics
Research, 11th Annual Conference
Improving Patient Safety: Reducing Drug-Drug Interactions
Daniel C. Malone, PhD, RPh
Tucson, Arizona
January 29, 2003
Hearing of the Subcommittee, United States Senate Committee on
Appropriations Subcommittee on Labor, Health and Human Services Education
and Related Agencies
Implementation of Smallpox Vaccination Plan
Brian L. Strom, MD, MPH
Washington, DC
January 28, 2003
University of Arizona Center for Health Outcomes and Pharmacoeconomics
Research, 11th Annual Conference
Health Literacy or Communication Failure? Dilemmas Facing Patients
and Providers
Mary Brown, PhD
Tucson, Arizona
January 24, 2003
UNC Program on Health Outcomes Seminar
Improving Cardiovascular Drug Therapy: The Duke Center for Education
and Research on Therapeutics
Judith M. Kramer, MD, MS
Chapel Hill, North Carolina
January 21, 2003
Institute of Medicine, Committee on Smallpox Vaccination Program
Implementation
Briefing of the Senate Health, Education, Labor and Pension Committee
Brian L. Strom, MD, MPH
Washington, DC
January 17, 2003
Grand Rounds at Santa Clara Medical Center
What You Should Know About the QT Interval
Sana Al-Khatib, PharmD
San José, California
January 13, 2003
CERTs Risk Management
Evaluation of Dofetilide
Nancy Allen LaPointe, PharmD
Chapel Hill, North Carolina
January 8, 2003
Division of Infections Diseases Conference
Antimicrobials and Medical Errors
Darren Linkin, MD
New York City, New York